Drug development moves fast — and the difference between a program that stalls and one that succeeds often comes down to experienced leadership at the right moment.
I'm Michael Cieslewicz, a drug development executive with 25+ years across academia, biotech, and pharma. I founded AbCie Consulting in 2024 to bring fractional program leadership and project management expertise to early-stage biotech companies as they navigate start-up and the path to the clinic. I bring an entrepreneurial mindset to that work, having joined Vigeo Therapeutics as the company's second hire and helped build its program management and operational infrastructure from the ground up.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.